Does Nirmatrelvir And Ritonavir Interact with Lidocaine?
Nirmatrelvir And Ritonavir and Lidocaine have a moderate drug interaction according to U.S. FDA drug labeling data. Caution warranted and therapeutic concentration monitoring recommended for systemic lidocaine. The mechanism involves cyp3a inhibition increases lidocaine plasma concentrations. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Lidocaine Class
- Amide Local Anesthetic
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Nirmatrelvir And Ritonavir and Lidocaine occurs because cyp3a inhibition increases lidocaine plasma concentrations. Clinically, this means caution warranted and therapeutic concentration monitoring recommended for systemic lidocaine. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Nirmatrelvir And Ritonavir and your doctor is considering prescribing Lidocaine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider